COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?"

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine.Allergy · 2022
   Article
2. COVID-19 Vaccination Is Safe among Mast Cell Disorder Patients, under Adequate Premedication.Vaccines · 2022
   Article
3. Allergo Journal : interdisziplinare Zeitschrift fur Allergologie und Umweltmedizin : Organ der Deutschen Gesellschaft fur Allergie- und Immunitatsforschung · 2022
   Review
4. COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: a review.3 Biotech · 2022
   Review
5. Evaluation of the Autoimmunity and Preexisting Risky Conditions for Hypersensitivity Reactions to COVID-19 Vaccines.International archives of allergy and immunology · 2022
   Article
6. Anaphylaxis to additives in vaccines.Allergo journal international · 2022
   Review
7. Do we miss rare adverse events induced by COVID-19 vaccination?Frontiers in medicine · 2022
   Review
8. Recent advances and developments in COVID-19 in the context of allergic diseases.Clinical and translational allergy · 2021
   Article
9. Allergic reactions to COVID-19 vaccinations-unveiling the secret(s).Allergy · 2021
   Article
10. Adverse reactions to COVID-19 vaccines: A practical approach.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2021
    Review
11. Clinical Effects of BNT162b2 Vaccine on the Short-Term Course of Chronic Spontaneous Urticaria Patients.Indian journal of dermatology
    Article

Corrections and comments

• Comment on
  COVID-19 vaccine anaphylaxis: PEG or not?2021

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as